Find clinical trials for Prostate Cancer in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near San Francisco, CA, USA:
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
Palo Alto, California, United States and 7 other locations
The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...
Phase 1
San Francisco, California, United States and 6 other locations
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
San Francisco, California, United States and 15 other locations
This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate...
Phase 3
San Francisco, California, United States and 30 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
San Francisco, California, United States and 9 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
San Francisco, California, United States and 34 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...
Phase 1
San Francisco, California, United States and 8 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
San Francisco, California, United States and 50 other locations
Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...
Phase 1, Phase 2
San Francisco, California, United States and 53 other locations
inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...
Phase 2
San Francisco, California, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal